Preview Mode Links will not work in preview mode

CQ on Congress


Nov 9, 2015

An estimated $60 billion worth of biotechnology drugs will lose patent protection next year and the Food and Drug Administration and the government’s top consumer watchdog agency can’t seem to agree on what to name cheaper, copycat versions. That could complicate efforts to hold down medical spending.